| 000 | 01662 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516022022.0 | ||
| 264 | 0 | _c20120517 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1468-1331 | ||
| 024 | 7 |
_a10.1111/j.1468-1331.2010.03345.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMatà , S | |
| 245 | 0 | 0 |
_aIgM monoclonal gammopathy-associated neuropathies with different IgM specificity. _h[electronic resource] |
| 260 |
_bEuropean journal of neurology _cAug 2011 |
||
| 300 |
_a1067-73 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 | _aAntibody Specificity |
| 650 | 0 | 4 |
_aAutoantibodies _xbiosynthesis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin M _xbiosynthesis |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMonoclonal Gammopathy of Undetermined Significance _xdrug therapy |
| 650 | 0 | 4 |
_aMyelin-Associated Glycoprotein _ximmunology |
| 650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xblood |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRituximab |
| 700 | 1 | _aBorsini, W | |
| 700 | 1 | _aAmbrosini, S | |
| 700 | 1 | _aToscani, L | |
| 700 | 1 | _aBarilaro, A | |
| 700 | 1 | _aPiacentini, S | |
| 700 | 1 | _aSorbi, S | |
| 700 | 1 | _aLolli, F | |
| 773 | 0 |
_tEuropean journal of neurology _gvol. 18 _gno. 8 _gp. 1067-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1468-1331.2010.03345.x _zAvailable from publisher's website |
| 999 |
_c20542655 _d20542655 |
||